Duke University and CoEHAR- together with Istituto Oasi Maria SS di Troina and the City Council- concluded the first part of the study to assess the prevalence of coronavirus infections in the city of Troina, a previous red zone due to the high rate of infections by COVID-19
CoEHAR’s researchers have just published the longest clinical follow-up of E-cigarette users ever reported. The study “COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up” explores the long term effects of E-cigarette use in patients with chronic obstructive pulmonary disease (COPD) and confirms that regular use can ameliorate objective and subjective COPD and is long lasting
In a recent study published on Journal of Clinical Medicine, there is now emerging evidence that obesity and overweight predispose to Covid-19 severe symptoms and negative prognosis
Expert Panel to Discuss Diversity and Harm Reduction in Global Tobacco Control Policy Virtual Webinar Sessions Sept.30 and Oct.1
Reflecting on the 15th Year of the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC), two international expert panel sessions featuring leading academics, researchers and NGO principals will cover the key questions and challenges facing policymakers in achieving more effective and equitable implementation globally
What are the best practises the tobacco industry should follow to achieve a sustainable change through the innovation and regulation? This was the question that this year’s Global Tobacco and Nicotine Forum, GTFN 2020, focused on
Tobacco Transformation Index finds most of the 15 Largest Tobacco Companies are failing to advance Harm Reduction
The first Tobacco Transformation Index, released today and made possible with funding from the Foundation for a Smoke-Free World, finds that most of the 15 largest tobacco companies are not making substantive progress in phasing out cigarettes and other high-risk tobacco products and transitioning smokers to reduced-risk alternatives
CoEHAR researchers call out the standardization of research methodologies on electronic cigarettes as a milestone for the effectiveness of the procedures to quit smoking
Presented in Italy the “Blue Book”, the document containing the results achieved last year by the Italian Customs and Monopoly Agency. The most impressive result was the contraction of 6.80% in...
According to a study lead by CoEHAR of the University of Catania, the e-liquids used in electronic cigarettes have antibacterial properties effective on different pathogens
PARTNERSHIPS BETWEEN COHEAR, DUKE UNIVERSITY, OASI OF TROINA LEADS TO THE FIRST STUDY TO EVALUATE THE CORRELATION BETWEEN SMOKING HABITS AND COVID-19 INFECTIONS.
In the past few days, seroepidemiological tests on citizens have been performed to assess the impact of smoking on the Covid-19 infections on the most vulnerable part of the population. The subjects of the study were selected according to a multi-layered probabilistic sampling plan by gender and age on citizens from 5 to over 80 years old. Among them, the employees of the Oasi of Troina, many of whom were tested positive to the Covid-19 infection.
New studies show flavoured vaping products are more effective for adults who want to quit smoking for good without relapsing.
THE NEW FRONTIERS OF REHABILITATION: VIRTUAL REALITY CAN HELP PEOPLE WITH SCHIZOPHRENIA SPECTRUM DISORDERS
A Systematic Review conducted by the researchers of the University of Catania and COEHAR suggests that Immersive Virtual Reality can be used to treat symptoms related to the spectrum of schizophrenia.
An article published in the Lancet triggers the reaction of the scientific community that supports the tobacco harm reaction policies.
QUIT STRONG is one of the first public health initiatives in the World that embrace THR (Tobacco Harm Reduction), showing openness to strategies that can support smokers during smoking cessation programmes. Low risk products allow to provide the necessary amount of nicotine while maintaining the behavioral and psychological rituals associated to smoking
On 22 July 2020, Smile Study started officially the operational phase of the projects with the training on the equipments and the visiting of first subjects enrolledDr. Elbert Waller of the Inspektor Research Systems has been welcomed in Catania for for the conduction of a training on the latest innovative technologies in dental diagnostic
Talking about tobacco harm reduction means embracing a plurality of behaviors, choices and products that can be confusing. We have deepened the subject with Dr. Renée O’Leary, author of the paper and COEHAR researcher
The road ahead for substitution of combustible cigarettes with low risk technologies as a strategy to reduce harm in the 21st Century
The article highlights why harm reduction is important, what are the ways to achieve harm reduction, particularly the use of snus, heated tobacco products and e-cigarettes and what are the barriers to use of such alternatives. This article is not a systematic or narrative review; it is an overview of recent studies on these products or devices. Industry conducted or funded studies were excluded from the review.
Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Unfortunately, socio-cultural and economics barriers, such as heavy taxation, misperceptions about nicotine and unsubstantiated fears of youth addiction, prevent low risk products to become accessible to all and a good choice for those who want to quit smoking.